Chemotherapy: advanced Hodgkin lymphoma - balancing toxicity and cure
Lim, Sean H. and Johnson, Peter W.M. (2011) Chemotherapy: advanced Hodgkin lymphoma - balancing toxicity and cure. Nature Reviews Clinical Oncology, 8, (11), 634-636. (doi:10.1038/nrclinonc.2011.137). (PMID:21894205).
Download
Full text not available from this repository.
Description/Abstract
The combination of doxorubicin, bleomycin, vincristine and dacarbazine (ABVD) has emerged as a standard of care in advanced-stage Hodgkin lymphoma over the past four decades. Clinicians treating patients with cancer frequently walk a tightrope where the requirements of efficacy have to be balanced against the morbidity caused by the treatment.
| Item Type: | Article |
|---|---|
| ISSNs: | 1759-4774 (print) 1759-4782 (electronic) |
| Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Faculty of Medicine > Cancer Sciences |
| Item ID: | 340837 |
| Date Deposited: | 04 Jul 2012 10:35 |
| Last Modified: | 26 Apr 2013 06:18 |
| Contributors: | Lim, Sean H. (Author) Johnson, Peter W.M. (Author) |
| Date: | November 2011 |
| Status: | Published |
| URI: | http://eprints.soton.ac.uk/id/eprint/340837 |
Actions (login required)
 |
View Item |
